gut
health
start
place
maintain
overal
health
anim
strategi
maintain
gut
health
thu
import
part
achiev
goal
improv
anim
health
new
strategi
involv
two
molecul
iron
transport
protein
ovotransferrin
polyethylen
glycol
succin
tpg
result
novel
formul
itpg
molecul
help
reduc
gut
pathogen
enhanc
absorpt
bioavail
therapeut
drug
phytomedicin
nanomedicin
turn
help
maintain
normal
health
anim
maintain
gastrointestin
tract
git
normal
condit
key
success
absorpt
efficaci
nutrient
compromis
git
due
imbal
dysbiosi
git
microbiom
lead
impair
gi
barrier
system
impair
absorpt
overal
health
anim
molecul
itpg
may
address
issu
poor
absorpt
keep
gi
system
healthi
maintain
normal
microbiom
improv
absorpt
nutrient
multipl
mechan
involv
antioxid
antiinflammatori
immunomodulatori
antimicrobi
activ
itpg
technolog
allow
dose
activ
pharmaceut
herbal
medicin
significantli
reduc
order
attain
equal
better
efficaci
complimentari
action
tpg
itpg
present
novel
approach
increas
bioavail
drug
phytoconstitu
nutrient
nanomedicin
enhanc
transport
tissu
site
action
reduc
gut
pathogen
load
itpg
approach
appear
novel
strategi
maintain
health
anim
manipul
microbiota
molecul
bioenhanc
herbal
nonherb
origin
indic
drug
phytochem
use
bioenhanc
potenti
date
back
thousand
year
piperin
black
pepper
appear
first
exampl
yogvahi
herb
abl
increas
potenti
plasma
concentr
drug
mention
ayurved
medicin
vivo
studi
peppermint
oil
report
increas
bioavail
cyclosporin
ginseng
polysaccharid
report
enhanc
absorpt
ginsenosid
vivo
studi
yurdakokdikmen
et
al
report
follow
oral
administr
biodegrad
herbal
drug
occur
stomach
gut
lumen
membran
permeabl
metabol
key
factor
absorpt
bioenhanc
variou
class
exert
effect
via
multipl
mechan
enzymat
alter
phytosom
formul
transport
protein
alter
cholagoguecholerect
effect
thermogenesi
absorpt
drugsphytoconstitu
enhanc
employ
variou
strategi
manipul
formul
micron
nanocrystalsnanosuspens
solid
solut
selfdispers
solid
solut
surfact
lipid
solut
selfemulsifi
drug
deliveri
system
surfactantcosolv
system
number
vivo
studi
properti
tpg
vitamin
e
tpg
describ
enhanc
deliveri
drug
nutraceut
nanoparticl
dietari
nutrient
poor
water
solubl
vitamin
e
limit
absorpt
git
esterif
vitamin
e
succin
polyethylen
glycol
peg
make
complet
water
solubl
tpg
amphiphil
structur
compris
hydrophil
polar
head
portion
lipophil
alkyl
tail
function
excel
solubil
emulsifi
permeat
bioavail
enhanc
hydrophob
drug
nutraceut
tpg
also
use
develop
nanomedicin
focus
simpl
structur
multifunct
properti
cours
prepar
nanomedicin
still
laboratori
scale
progress
develop
novel
nanomedicin
rel
slow
vitro
vivo
studi
tpg
also
shown
exhibit
addit
properti
surfact
apoptogen
anticanc
immunomodul
neuroprotect
revers
multidrug
resist
mdr
inhibit
pglycoprotein
pgp
activ
tpg
denot
peg
chain
molecular
weight
approv
fda
gra
supplement
solubil
drug
oral
parenter
topic
nasal
rectalvagin
therapi
tpg
also
approv
european
food
safeti
author
efsa
safe
pharmaceut
adjuv
use
drug
formul
research
purpos
vitamin
e
tpg
power
tool
formul
poorlysolubl
lipophil
compound
enhanc
absorpt
bioavail
via
effici
micellar
uptak
enterocyt
tpg
proven
record
safeti
efficaci
pharmaceut
dietari
supplement
food
beverag
person
care
anim
nutrit
cannabinoid
product
ad
benefit
clean
label
ingredi
order
achiev
greater
stabil
bioavail
addit
biologicalpharmacolog
effect
better
therapeut
efficaci
tpg
technolog
improvis
combin
iron
transport
protein
ovotransferrin
tpg
formul
iron
transport
polyethylen
glycol
succin
itpg
solubl
fat
water
exert
multipl
biolog
pharmacolog
effect
antioxid
antiinflammatori
antimicrobi
immunomodulatori
healthi
gut
overal
health
improv
review
describ
variou
facet
itpg
includ
formul
biolog
properti
pharmacolog
mechan
therapeut
efficaci
polyethylen
glycol
succin
tpg
prepar
natur
lipidsolubl
vitamin
e
graft
polyethylen
glycol
peg
oligom
succin
diester
linker
iron
transport
polyethylen
glycol
succin
itpg
molecul
addit
natur
incorpor
iron
transport
aspect
ovotransferrin
formerli
known
conalbumin
obtain
eggwhit
hydrolys
structur
formula
itpg
ittpg
shown
figur
intestin
health
critic
import
welfar
perform
anim
human
enter
diseas
affect
structur
integr
gastrointestin
tract
git
lead
high
econom
loss
due
reduc
weight
gain
poor
feed
convers
effici
increas
mortal
rate
greater
medic
cost
overal
health
anim
typic
start
gut
due
two
key
aspect
gut
site
bodi
anim
absorb
nutrient
also
pathogen
usual
encount
first
research
thu
focus
effort
identifi
method
maintain
overal
health
anim
use
nutraceut
one
method
vivo
studi
mani
nutraceut
report
poorli
absorb
git
thu
limit
bioavail
dissolut
abil
permeat
gi
wall
consid
major
barrier
drugphytomedicin
bioavail
result
concentr
bioactiv
phytoconstitu
target
site
low
therebi
minim
effect
addit
low
bioavail
natur
product
poor
solubl
stabil
overcom
obstacl
natur
incorpor
iron
transport
aspect
ovotransferrin
formerli
known
conalbumin
obtain
eggwhit
hydrolys
structur
formula
itpg
ittpg
shown
figur
tocopheryl
polyethylen
glycol
succin
tpg
use
mani
purpos
includ
effici
sourc
natur
vitamin
e
therapeut
nutrit
purpos
vitamin
e
tpg
watersolubl
deriv
vitamin
e
nonion
surfact
use
solubil
absorpt
enhanc
emulsifi
vehicl
lipidbas
drugherb
formul
antioxid
itpg
contain
iron
ovotransferrin
offer
possibl
vastli
improv
effect
maintain
normal
health
especi
exert
antimicrobi
effect
gut
pathogen
typic
encount
first
anim
vitro
vivo
studi
ovotransferrin
report
involv
iron
transport
iron
deliveri
antibacteri
immunomodulatori
ro
scaveng
activ
iron
transport
itpg
appear
uniqu
novel
composit
two
moieti
wide
rang
biolog
pharmacolog
activ
past
number
drug
deliveri
system
includ
liposom
formul
nanoparticl
nanocryst
nanosuspens
micellar
formul
develop
investig
enhanc
absorpt
bioavail
itpgstpg
may
increas
bioavail
pharmaceut
herbal
product
nanomedicin
also
nutrient
otherwis
poorli
solubl
less
bioavail
itpg
potenti
maintain
healthi
gut
environ
normal
enterocyt
improv
uptak
transport
bioavail
nutrient
mechan
watersolubl
tpg
enter
enterocyt
becom
absorb
describ
neophyt
constantin
tpg
portion
itpg
hydrolyz
free
stomach
nonenzymat
hydrolysi
proxim
brush
border
epithelium
esteras
hydrolysi
surfac
enterocyt
via
lipas
micel
tocopheryl
polyethylen
glycol
succin
tpg
use
mani
purpos
includ
effici
sourc
natur
vitamin
e
therapeut
nutrit
purpos
vitamin
e
tpg
watersolubl
deriv
vitamin
e
nonion
surfact
use
solubil
absorpt
enhanc
emulsifi
vehicl
lipidbas
drugherb
formul
antioxid
itpg
contain
iron
ovotransferrin
offer
possibl
vastli
improv
effect
maintain
normal
health
especi
exert
antimicrobi
effect
gut
pathogen
typic
encount
first
anim
vitro
vivo
studi
ovotransferrin
report
involv
iron
transport
iron
deliveri
antibacteri
immunomodulatori
ro
scaveng
activ
iron
transport
itpg
appear
uniqu
novel
composit
two
moieti
wide
rang
biolog
pharmacolog
activ
past
number
drug
deliveri
system
includ
liposom
formul
nanoparticl
nanocryst
nanosuspens
micellar
formul
develop
investig
enhanc
absorpt
bioavail
itpgstpg
may
increas
bioavail
pharmaceut
herbal
product
nanomedicin
also
nutrient
otherwis
poorli
solubl
less
bioavail
itpg
potenti
maintain
healthi
gut
environ
normal
enterocyt
improv
uptak
transport
bioavail
nutrient
mechan
watersolubl
tpg
enter
enterocyt
becom
absorb
describ
neophyt
constantin
tpg
portion
itpg
hydrolyz
free
stomach
nonenzymat
hydrolysi
proxim
brush
border
epithelium
esteras
hydrolysi
surfac
enterocyt
via
lipas
micel
itpg
substanc
potenti
pass
cell
membran
therebi
enabl
absorpt
itpg
observ
tpg
vivo
vitro
studi
suggest
absorpt
bioavail
intracellular
uptak
local
greater
natur
isoform
vitamin
e
follow
oral
administr
mice
khanna
et
al
found
detect
level
isoform
skin
heart
lung
brain
liver
bone
marrow
blood
suggest
isoform
vitamin
e
effect
transport
variou
organ
display
nonspecif
distribut
tissu
vivo
studi
uptak
distribut
vitamin
e
shown
increas
make
water
solubl
tpg
itpg
form
vivo
vitro
studi
watersolubl
vitamin
e
tpg
investig
variou
properti
solubil
micellar
properti
surfact
addit
emulsifi
drug
formul
drug
deliveri
system
pgp
inhibitor
oral
absorpt
enhanc
permeat
enhanc
bioavail
enhanc
atpbind
cassett
superfamili
contain
membran
transport
protein
transport
wide
rang
divers
compound
across
cellular
membran
pgp
import
member
famili
multispecif
drug
efflux
transport
play
signific
role
govern
bioavail
mani
clinic
activ
drug
pgp
primarili
thought
serv
natur
protect
function
transport
substanc
includ
toxin
bacteria
cell
pgp
epitheli
cell
membran
protein
locat
apic
membran
function
multidrug
efflux
pump
tpg
act
revers
agent
pgp
mediat
mdr
inhibit
pgp
mediat
drug
transport
find
suggest
enhanc
oral
bioavail
drug
coadminist
tpg
may
part
due
inhibit
pgp
intestin
observ
tpg
coadministr
itpg
may
enhanc
drug
solubl
enhanc
pgp
mediat
mdr
increas
oral
bioavail
cellular
uptak
drug
nanoparticl
herbal
medicin
collnot
et
al
investig
tpg
analog
vari
peg
chain
length
andor
possess
modifi
hydrophob
core
transport
studi
reveal
modul
atpas
activ
correl
inhibitori
potenti
pgp
mediat
efflux
investig
suggest
atpas
inhibit
essenti
factor
inhibitori
mechan
tpg
cellular
efflux
pump
mechanist
understand
inhibit
pgp
tpg
give
new
insight
structur
activ
relationship
improv
ration
design
potent
pgp
inhibitor
vivo
studi
chen
et
al
demonstr
tpg
significantli
enhanc
oral
bioavail
phytomedicin
berberin
chlorid
bbr
peak
concentr
c
max
increas
time
area
curv
auc
increas
time
rat
report
bbr
substrat
pgp
pgp
play
import
role
absorpt
bbr
absorpt
enhanc
properti
tpg
may
due
abil
affect
biolog
activ
pgp
therebi
reduc
excret
absorb
bbr
intestin
lumen
current
tpg
consid
proven
bioenhanc
bbr
tpg
also
report
enhanc
absorpt
bioavail
sever
drug
differ
class
number
vivo
studi
tpg
also
shown
enhanc
absorpt
bioavail
nutraceut
hypothes
itpg
expect
better
bioenhanc
tpg
potenti
less
pathogen
bacteria
present
less
energi
requir
enterocyt
gut
fight
pathogen
antioxid
properti
itpg
base
hydrolysi
cytoplasm
esteras
liber
free
local
cell
membran
quench
free
radic
protect
membran
lipid
peroxid
damag
itpg
work
free
radic
scaveng
antioxid
stress
cell
therebi
promot
healthi
environ
tpg
ovotransferrin
molecul
shown
antioxid
properti
via
differ
mechan
vitro
vivo
studi
isoform
natur
vitamin
e
report
exert
variou
biolog
pharmacolog
properti
antioxid
antiinflammatori
neuroprotect
antithrombot
anticanc
previou
vitro
vivo
studi
shown
mitochondria
contain
highest
concentr
vitamin
e
analog
vitamin
e
acceler
atp
resynthesi
vitamin
e
mainli
act
chainbreak
antioxid
radic
scaveng
protect
cell
membran
oxid
damag
addit
vitamin
e
regul
ro
product
maintain
oxid
phosphoryl
mitochondria
acceler
restitut
highenergi
phosphat
vitro
studi
mitochondri
target
succin
shown
exert
apoptot
anticanc
properti
vitro
vivo
studi
well
establish
isoform
vitamin
e
addit
antioxid
properti
interact
enzym
protein
lipid
transcript
factor
inhibit
function
pkc
phospholipas
posttranscript
level
activ
phosphatas
also
report
inhibit
cellular
prolifer
platelet
aggreg
monocyt
attach
antioxid
effect
attribut
ovotransferrin
well
vitro
vivo
studi
also
shown
ovotransferrin
enhanc
antioxid
effect
nutraceut
ingredi
exampl
conjug
ovotransferrin
catechin
show
improv
antioxid
activ
gastrointestin
inflamm
induc
larg
number
microorgan
microbi
imbal
dysbiosi
caus
sever
factor
diet
diseas
infect
medic
toxic
age
etc
dysbiot
microbiota
may
suffici
provok
intestin
inflamm
seen
inflammatori
bowel
diseas
much
current
interest
quantit
andor
qualit
abnorm
microbiota
may
associ
system
immun
allerg
obes
metabol
infecti
disord
periodont
respiratori
diseas
cancer
number
vivo
vitro
studi
interact
gut
microbiota
immun
system
investig
nieuwenhuizen
et
al
hypothes
failur
gut
import
pathophysiolog
phenomenon
gener
inflammatori
respons
lead
multipl
organ
dysfunct
syndrom
mod
abnorm
colon
infect
gut
origin
bacteri
transloc
sign
gut
failur
implic
pathogenesi
mod
vitro
studi
talukd
et
al
examin
action
lactoferrin
lf
prevent
prostaglandin
e
pge
effect
na
depend
glucos
cotransport
glucos
absorpt
enterocyt
investig
grew
intestin
epitheli
cell
transwel
plate
treat
phlorizin
pge
lf
perform
dglucopyranos
omg
uptak
within
day
postconflu
na
depend
omg
uptak
phlorizin
immunoblot
studi
show
activ
apic
membran
local
cell
find
reveal
pge
inhibit
concentrationand
timedepend
manner
inhibitori
constant
ki
nmoll
antagon
prostanoid
receptor
inhibitor
also
observ
pge
alter
na
k
atpas
activ
contrast
quantit
realtim
polymeras
chain
reaction
qrtpcr
western
blot
analysi
reveal
transcript
protein
express
level
decreas
pge
furthermor
pge
treatment
increas
intracellular
camp
ca
concentr
decreas
express
apic
membran
effect
amelior
lf
conclud
lf
amelior
pge
inhibit
via
ca
campsign
pathway
figur
taken
togeth
iron
bind
protein
molecul
lf
ovotransferrin
appear
play
import
role
significantli
reduc
inflamm
intestin
restor
absorpt
nutrient
quantiti
protein
apic
membran
reduc
na
glucos
na
depend
glucos
uptak
reduc
lfr
lf
receptor
lf
lactoferrin
endocytos
receptormedi
transcytosi
inhibit
upregul
ca
camp
level
increas
na
glucos
uptak
depend
cell
increas
vmax
courtesi
talukd
et
al
reason
believ
ovotransferrin
may
also
work
manner
similar
mechan
increas
glucos
uptak
itpg
work
inflammatori
regul
balanc
maintain
normal
gut
health
iron
greatli
requir
pathogen
bacteria
metabol
process
growth
replic
contrast
probiot
nonpathogen
bacteria
need
much
iron
molecul
sequest
iron
depriv
pathogen
bacteria
iron
addit
molecul
caus
osmolysi
thu
molecul
act
bacteriostat
bactericid
pathogen
bacteria
kill
probiot
gut
furthermor
itpg
appear
maintain
healthi
inflammatori
respons
bodi
regul
biomark
interleukin
tnfalpha
antiinflammatori
properti
itpg
also
attribut
vitamin
e
vitro
vivo
studi
suggest
iron
fe
fe
bind
protein
transferrin
ovotransferrin
eggwhit
lactoferrin
colostrum
milk
exert
antimicrobi
immunomodulatori
antiinflammatori
properti
anticanc
effect
vitro
studi
valenti
et
al
report
pseudomona
spp
escherichia
coli
streptococcu
reason
believ
ovotransferrin
may
also
work
manner
similar
mechan
increas
glucos
uptak
itpg
work
inflammatori
regul
balanc
maintain
normal
gut
health
iron
greatli
requir
pathogen
bacteria
metabol
process
growth
replic
contrast
probiot
nonpathogen
bacteria
need
much
iron
molecul
sequest
iron
depriv
pathogen
bacteria
iron
addit
molecul
caus
osmolysi
thu
molecul
act
bacteriostat
bactericid
pathogen
bacteria
kill
probiot
gut
furthermor
itpg
appear
maintain
healthi
inflammatori
respons
bodi
regul
biomark
interleukin
tnfalpha
antiinflammatori
properti
itpg
also
attribut
vitamin
e
vitro
vivo
studi
suggest
iron
fe
fe
bind
protein
transferrin
ovotransferrin
eggwhit
lactoferrin
colostrum
milk
exert
antimicrobi
immunomodulatori
antiinflammatori
properti
anticanc
effect
vitro
studi
valenti
et
al
report
pseudomona
spp
escherichia
coli
streptococcu
mutan
sensit
proteu
spp
klebsiella
spp
resist
antibacteri
action
ovotransferrin
molecul
starv
pathogen
bacteria
gram
posit
gram
neg
iron
molecul
greatli
enhanc
probiot
bacteria
lactobacillu
bifidobacteria
addit
endometr
usual
caus
infect
dairi
cow
within
day
postpartum
deterior
health
decreas
milk
product
caus
huge
econom
loss
farm
unpublish
vivo
studi
molecul
show
rectal
temperatur
return
normal
one
week
intrauterin
ovotransferrin
treatment
mean
ph
uterin
discharg
metriti
cow
control
chang
one
week
ovotransferrin
treatment
mucu
score
time
higher
total
number
polymorph
time
higher
cow
metriti
significantli
p
reduc
time
respect
compar
control
ovotransferrin
treatment
bacteri
cultur
uterin
swab
demonstr
presenc
differ
type
bacteria
includ
gram
posit
gram
neg
rod
cocci
zone
inhibit
studi
differ
concentr
ovotransferrin
demonstr
would
enough
kill
type
bacteria
found
studi
thu
conclud
molecul
potent
antimicrobi
protein
abil
kill
differ
type
bacteria
gut
especi
pathogen
bacteria
requir
iron
vitro
clinic
applic
numer
pathogen
bacteria
need
iron
surviv
mani
probiot
spp
lactobacillu
spp
need
less
iron
iron
surviv
inde
oral
administ
iron
direct
impact
microbi
composit
gut
result
reduct
benefici
microbiota
expans
pathobiont
also
provid
opportun
expans
enter
pathogen
concept
limit
enough
iron
gut
may
benefici
aspect
gener
health
anim
itpg
promot
healthi
gut
environ
normal
microbi
growth
thu
nutrient
readili
absorb
due
reduct
pathogen
bacteria
may
compet
nutrient
gut
itpg
molecul
absorb
exert
biolog
pharmacolog
action
ovotransferrin
depriv
pathogen
bacteria
iron
nutrient
need
surviv
keep
mind
tpg
inhibit
pgp
necessari
reduc
pathogen
may
produc
toxin
would
normal
remov
enterocyt
pgp
combin
tpg
ovotransferrin
allow
occur
less
pathogen
bacteria
present
git
may
promot
growth
probiot
bacteria
therebi
creat
healthi
microbi
balanc
addit
molecul
improv
health
intestin
villi
scaveng
free
radic
reduc
oxid
stress
thu
improv
healthi
inflammatori
respons
relev
gut
microbiom
microbiota
well
establish
health
diseas
human
anim
healthi
gut
microbi
ecosystem
exist
eubiosi
state
character
domin
potenti
benefici
microbi
speci
howev
dysbiosi
imbal
composit
number
gut
commens
microorgan
character
heavi
load
pathogen
bacteria
alter
gut
microbiom
emerg
evid
suggest
dysbiosi
may
advers
influenc
intestin
microbiom
eventu
gi
structur
function
indiscrimin
use
antibiot
chemotherapi
stress
implic
develop
dysbiosi
host
iron
dietari
iron
report
alter
microbiota
composit
lead
dysbiosi
recent
studi
effect
ovotransferrin
investig
cyclophosphamideinduc
intestin
microbiota
dysbiosi
studi
suggest
ovotransferrin
improv
divers
rich
intestin
microbiom
therefor
itpg
like
revers
dysbiosi
eubiosi
current
larg
number
vivo
studi
suggest
nutraceut
includ
prebiot
probiot
synbiot
use
maintain
normal
gut
biota
prevent
treat
gitrel
diseas
git
contain
complex
polymicrobi
commun
consist
bacteria
virus
archaea
fungi
parasit
bacteri
commun
promin
import
factor
maintain
homeostasi
complex
gut
environ
human
gut
microbiota
compos
one
hundr
trillion
microbi
cell
includ
aerob
anaerob
speci
well
gramposit
gramneg
speci
term
microbiota
defin
set
commens
autochthon
microorgan
coexist
host
without
caus
harm
freter
defin
intestin
microbiota
usual
complex
mixtur
bacteri
popul
colon
given
area
git
individu
human
anim
host
affect
medic
experiment
intervent
diseas
gut
microbiota
differ
substanti
among
anim
strain
speci
gender
human
anim
well
establish
microbiota
play
great
role
health
git
well
vital
organ
git
largest
reservoir
commens
bacteria
human
anim
bodi
provid
nutrient
space
surviv
microb
concurr
oper
mucos
barrier
confin
microbi
popul
commens
organ
known
promot
gut
health
induct
mucu
product
enterocyt
turnov
gut
microbiota
key
factor
shape
biochem
profil
diet
therefor
impact
host
health
diseas
vitro
studi
yu
et
al
also
describ
epitheli
cell
link
tight
junction
physic
separ
microbiota
lamina
propria
also
secret
proinflammatori
cytokin
reactiv
oxygen
speci
ro
respons
pathogen
invas
metabol
stress
serv
sentinel
underli
immun
cell
commens
bacteria
involv
variou
physiolog
function
gut
inflamm
microbi
imbal
dysbiosi
may
caus
bacteri
invas
patholog
vitro
vivo
studi
rowland
et
al
describ
gut
microbiotaderiv
product
absorb
gut
enter
host
endogen
exogen
pathway
influenc
overal
metabol
phenotyp
host
addit
metabolit
gener
host
secret
gut
via
enterohepat
circul
serv
substrat
resid
microb
evid
vivo
vitro
studi
gut
microbiota
influenc
metabol
health
diseas
git
also
vital
organ
includ
liver
kidney
nervou
system
immun
system
recent
vivo
studi
investig
interact
microbi
commun
host
shown
gut
bacteria
caus
contribut
occurr
condit
allergi
inflammatori
bowel
diseas
rectal
cancer
diabet
obes
behavior
alter
fact
failur
gut
lead
mod
case
gut
dysfunct
preced
develop
mod
plausibl
gut
bacteria
may
initi
perpetu
product
local
inflammatori
mediat
may
produc
distant
organ
injuri
escherichia
coli
one
import
caus
diarrhea
human
anim
antibacteri
activ
ovotransferrin
toward
escherichia
coli
strain
test
valenti
et
al
bacteri
growth
measur
colonyform
unit
cfu
result
antibacteri
activ
ovotransferrin
shown
figur
antibacteri
activ
increas
concentr
ovotransferrin
indic
presenc
ovotransferrin
slow
chang
progress
limit
abil
grow
may
occur
microorgan
could
argu
therefor
chang
reflect
direct
interact
protein
bacteria
depriv
intern
iron
pool
slow
equilibrium
medium
molecul
x
peer
review
lactoferrin
ironbind
glycoprotein
belong
transferrin
protein
famili
ovotransferrin
also
belong
lactoferrin
antioxid
antimicrobi
properti
use
treat
diarrhea
use
includ
stimul
immun
system
prevent
tissu
damag
relat
age
promot
healthi
intestin
bacteria
prevent
cancer
regul
way
bodi
process
iron
iron
bind
action
ovotransferrin
lactoferrin
make
use
research
function
similar
function
substitut
formul
exampl
vitro
studi
valenti
et
al
show
ovotransferrin
lactoferrin
nearli
ident
abil
antimicrobi
activ
e
coli
streptococcu
mutan
suggest
function
equival
ovotransferrin
lactoferrin
least
bacteriostat
action
pathogen
bacteria
provid
rational
ovotransferrin
formul
may
reli
lactoferrin
exampl
ovotransferrin
may
equival
lactoferrin
vivo
studi
talukd
harada
investig
effect
ironbind
multifunct
glycoprotein
bovin
lactoferrin
blf
lipopolysaccharid
lp
induc
diarrheagen
activ
gi
transit
intestin
fluid
content
mice
investig
found
lp
accumul
abund
fluid
small
intestin
dosedepend
manner
induc
diarrhea
decreas
gi
transit
observ
pretreat
blf
significantli
attenu
effect
lp
diarrheagen
activ
intestin
content
revers
gi
transit
time
compar
ngnitrolargininemethyl
ester
lname
nonselect
no
inhibitor
indomethacin
inhibitor
prostaglandin
synthesi
addit
plasma
enterocyt
found
increas
lpstreat
mice
revers
blf
conclud
action
blf
lp
specif
exert
antidiarrh
antiinflammatori
activ
modul
cyclooxygenas
pathway
gut
ovotransferrin
lactoferrin
similar
antimicrobi
action
possibl
ovotransferrin
may
similar
mode
action
lactoferrin
potenti
antidiarrh
antiinflammatori
activ
vitro
studi
turnov
rate
intestin
epitheli
cell
enterocyt
govern
pace
crypt
cell
prolifer
villussurfac
cell
shed
vitro
studi
shown
tight
junction
protein
present
base
basolater
membran
two
neighbor
enterocyt
flank
extrud
cell
thu
barrier
function
sustain
villu
tip
excess
epitheli
cell
death
pathogen
microb
metabol
stress
lactoferrin
ironbind
glycoprotein
belong
transferrin
protein
famili
ovotransferrin
also
belong
lactoferrin
antioxid
antimicrobi
properti
use
treat
diarrhea
use
includ
stimul
immun
system
prevent
tissu
damag
relat
age
promot
healthi
intestin
bacteria
prevent
cancer
regul
way
bodi
process
iron
iron
bind
action
ovotransferrin
lactoferrin
make
use
research
function
similar
function
substitut
formul
exampl
vitro
studi
valenti
et
al
show
ovotransferrin
lactoferrin
nearli
ident
abil
antimicrobi
activ
e
coli
streptococcu
mutan
suggest
function
equival
ovotransferrin
lactoferrin
least
bacteriostat
action
pathogen
bacteria
provid
rational
ovotransferrin
formul
may
reli
lactoferrin
exampl
ovotransferrin
may
equival
lactoferrin
vivo
studi
talukd
harada
investig
effect
ironbind
multifunct
glycoprotein
bovin
lactoferrin
blf
lipopolysaccharid
lp
induc
diarrheagen
activ
gi
transit
intestin
fluid
content
mice
investig
found
lp
accumul
abund
fluid
small
intestin
dosedepend
manner
induc
diarrhea
decreas
gi
transit
observ
pretreat
blf
significantli
attenu
effect
lp
diarrheagen
activ
intestin
content
revers
gi
transit
time
compar
ngnitrolargininemethyl
ester
lname
nonselect
no
inhibitor
indomethacin
inhibitor
prostaglandin
synthesi
addit
plasma
pge
enterocyt
found
increas
lpstreat
mice
revers
blf
conclud
action
blf
lp
specif
exert
antidiarrh
antiinflammatori
activ
modul
cyclooxygenas
pathway
pge
gut
ovotransferrin
lactoferrin
similar
antimicrobi
action
possibl
ovotransferrin
may
similar
mode
action
lactoferrin
potenti
antidiarrh
antiinflammatori
activ
vitro
studi
turnov
rate
intestin
epitheli
cell
enterocyt
govern
pace
crypt
cell
prolifer
villussurfac
cell
shed
vitro
studi
shown
tight
junction
protein
present
base
basolater
membran
two
neighbor
enterocyt
flank
extrud
cell
thu
barrier
function
sustain
villu
tip
excess
epitheli
cell
death
pathogen
microb
metabol
stress
nonsteroid
antiinflammatori
drug
nsaid
acid
enzymat
agent
may
lead
villou
surfac
denatur
gut
leaki
essenc
use
microbiota
manipul
improv
anim
health
promis
ongo
field
research
nutraceut
commonli
use
improv
gut
dysbiosi
bioavail
often
poor
itpg
shown
facilit
mainten
healthi
microbiota
microbiom
git
rodent
therefor
may
enhanc
absorpt
nutraceut
intestin
epithelium
maintain
physic
barrier
prevent
microbi
invas
concomitantli
modul
immun
compon
activ
host
defens
elimin
invad
pathogen
barrier
immun
function
intestin
epithelium
coexist
equal
import
mission
maintain
optim
environ
absorpt
nutrient
mainten
electrolyt
balanc
vitro
vivo
studi
demonstr
normal
microbiota
exert
profound
effect
mucos
immun
system
gut
regul
immun
respons
outsid
gut
mazmanian
et
al
provid
molecular
basi
hostbacteri
symbiosi
reveal
archetyp
molecul
commens
bacteria
exampl
polysaccharid
bacteroid
fragili
mediat
develop
host
immun
system
microbiota
play
pivot
role
regul
immunolog
toler
allergen
exposur
outsid
git
molecul
ovotransferrin
donor
iron
itpg
wide
rang
biofunct
major
compon
mammalian
innat
immun
system
porcin
epidem
diarrhea
viru
pedv
corona
viru
caus
enter
diseas
pig
produc
acut
sever
diarrhea
transmit
rapidli
pig
age
unpublish
data
vivo
studi
show
ovotransferrin
also
effect
control
diarrhea
caus
pedv
differ
group
piglet
treat
electrolyt
complet
protect
mortal
ittreat
group
data
show
electrolyt
combin
potent
enough
control
sever
diarrhea
avian
coccidiosi
infecti
protozoan
diseas
caus
eimeria
one
import
diseas
poultri
caus
tremend
loss
industri
throughout
world
protozoa
infect
multipli
within
mucos
epithelia
differ
part
gut
via
oral
ingest
result
caus
inflamm
hemorrhag
diarrhea
may
lead
death
thu
morbid
mortal
poultri
cost
poultri
industri
global
loss
billion
us
dollar
annual
seventi
percent
estim
cost
due
subclin
coccidiosi
impact
weight
gain
feed
convers
ratio
fcr
recent
unpublish
data
vivo
studi
show
prevent
e
tenella
infest
day
old
chick
addit
weight
gain
significantli
increas
ittreat
group
thu
use
treat
control
subclin
coccidiosi
prevent
morbid
mortal
poultri
industri
improv
gut
health
sound
strategi
improv
overal
health
anim
new
method
improv
art
novel
itpg
strategi
one
develop
iron
transport
polyethylen
glycol
succin
itpg
uniqu
formul
consist
ovotransferrin
natur
sourc
egg
format
abil
iron
bind
tocopheryl
polyethylen
glycol
succin
appear
exert
complimentari
action
bodi
itpg
may
serv
multifunct
molecul
solubil
stabil
surfact
addit
emulsifi
absorpt
enhanc
permeat
enhanc
offer
sustain
target
deliveri
pharmaceut
nutraceut
nanomedicin
itpg
exert
antioxid
antiinflammatori
immunomodulatori
antimicrobi
mani
biolog
pharmacolog
action
itpg
formul
may
prove
superior
biomateri
enhanc
efficaci
micel
nanoparticl
liposom
drug
deliveri
system
may
hope
futur
studi
alreadi
shown
itpg
formul
efficaci
safe
clinic
set
treat
enter
diseas
via
antimicrobi
antioxid
activ
microbi
imbal
caus
sever
factor
result
comorbid
situat
gut
use
itpg
may
great
use
especi
polypharmaci
approach
use
treat
patient
would
potenti
due
less
total
drug
use
patient
chanc
cross
drug
interact
toxic
could
minim
iptg
method
influenc
commens
microbiota
associ
medic
comorbid
begin
uncov
howev
clear
multimorbid
associ
use
multipl
medicin
common
older
popul
use
itpg
methodolog
polypharmaci
approach
use
may
real
valu
age
popul
human
anim
research
need
conduct
applic
comorbid
polypharmaci
condit
possibl
strategi
help
maintain
improv
gut
health
thu
improv
overal
health
anim
seem
hope
fund
research
receiv
extern
fund
